Category Archives: Abstracts

Interpretable framework for predicting preoperative cardiorespiratory fitness using wearable data.

Hussain I; Department of Anesthesiology, Weill Cornell Medicine, United States.
Zeepvat J; Reid MC; Czaja S; Pryor KO; Boyer R

Computer Methods & Programs in Biomedicine. 271:108980, 2025 Nov.

OBJECTIVES: Predicting preoperative cardiorespiratory fitness (CRF) is
crucial for assessing the risk of complications and adverse outcomes in
patients undergoing surgery. CRF is formally evaluated through submaximal
exercise testing with cardiopulmonary exercise testing (CPET) or the
6-minute walk test (6MWT). However, formal CRF testing is impractical as a
preoperative screening tool. Wrist-worn devices with actigraphy and heart
rate monitoring have become increasingly capable of predicting
physiological measurements. Our aim was to develop a clinically
interpretable machine learning (ML) model using wearable-derived
physiological data to predict CRF for older adults, and to access whether
this model can accurately estimate the 6MWT distances for preoperative
risk evaluation.

METHODS: We examined heart rate and activity data collected from Fitbit
devices worn by older adults (N = 65) who were scheduled to undergo major
noncardiac surgery. Data collection took place over a 1-week period prior
to surgery while participants engaged in their typical daily activities.
Our primary aim was to leverage this wearable technology to forecast CRF
among this group. We employed a machine-learning ensemble regression model
to predict CRF, using 6MWT outcomes as an index. Further, we applied the
shapley feature attribution approach to gain insights into how specific
features derived from wearable data contribute to CRF prediction within
the model, aiding in personalized fitness prediction.

RESULTS: Adults with higher CRF exhibited elevated levels of
moderate-to-vigorous physical activity (MVPA), maximal activity energy
expenditure (aEEmax), heart rate recovery (HRR), and non-linear heart rate
variability (HRV). These measures increased concurrently with improvements
in 6MWT outcomes. Our regression models, employing random forest and
linear regression techniques, demonstrated strong predictive capabilities,
with coefficient of determination values of 0.91 and 0.81, respectively,
for estimating CRF. The shapley feature attribution approach elucidated
those greater levels of MVPA, aEEmax, HRR, and nonlinear dynamics of HRV
serve as reliable indicators of enhanced CRF test performance.

CONCLUSION: The integration of wearable data-driven activity and heart
rate metrics forms the basis for utilizing wearables to provide
preoperative cardiorespiratory fitness assessments, supporting surgical
risk stratification, personalized prehabilitation, and improved patient
outcomes.

VI 1

VO2 Max in Clinical Cardiology: Clinical Applications, Evidence Gaps, and Future Directions. [Review]

Abdalla HM; Department of Internal Medicine, Mayo Clinic, USA.
Dreher L; VanDolah H; Bacon A; El-Nayir M; Abdelnabi M;
Ibrahim R; Pham HN; Bcharah G; Pathangey G; Wheatley-Guy C; Reddy S;
Farina J; Ayoub C; Arsanjani R

Current Cardiology Reports. 27(1):130, 2025 Sep 06. VI 1

PURPOSE OF REVIEW: VO2 max is a fundamental marker of cardiorespiratory
fitness with substantial prognostic and diagnostic value within the field
of cardiology. This review analyzes current and emerging evidence
regarding its clinical uses, highlights key evidence gaps, and explores
emerging developments poised to broaden its clinical application.

RECENT FINDINGS: Evidence supports VO2 max as a powerful independent
predictor for heart failure, coronary artery disease, hypertrophic
cardiomyopathy, and cardiac amyloidosis, supporting it use in identifying
high-risk patients for advanced interventions. Recent developments
including the integration of machine learning and wearable devices can
facilitate accurate VO2 estimation in routine clinical practice without
the necessity of specialized diagnostic tools. Despite its robust
diagnostic and prognostic value, VO2 max assessment remains underutilized
in routine cardiovascular care, primarily due to the need for specialized
equipment and personnel. Future research should explore emerging
technological innovations for VO2 max estimation and the development of
evidence-based protocols to support i

Cardiopulmonary exercise testing parameters in healthy athletes vs. equally fit individuals with hypertrophic cardiomyopathy.

McHugh C; Cardiology Division, Massachusetts General Hospital, Boston,  USA.
Gustus SK; Petek BJ; Schoenike MW; Boyd KS; Kennett JB; VanAtta
C; Tower-Rader AF; Fifer MA; DiCarli MF; Wasfy MM

European Journal of Preventive Cardiology. 32(12):1112-1119, 2025 Sep 08. VI 1

AIMS: Cardiopulmonary exercise testing (CPET) is often used when athletes
present with suspected hypertrophic cardiomyopathy (HCM). While low peak
oxygen consumption (pVO2) augments concern for HCM, athletes with HCM
frequently display supranormal pVO2, which limits this parameter’s
diagnostic utility. We aimed to compare other CPET parameters in healthy
athletes and equally fit individuals with HCM.

METHODS AND RESULTS: Using cycle ergometer CPETs from a single centre, we
compared ventilatory efficiency and recovery kinetics between individuals
with HCM [percent predicted pVO2(ppVO2) > 80%, non-obstructive, no nodal
agents] and healthy athletes, matched (2:1 ratio) for age, sex, height,
weight and ppVO2. Consistent with matching, HCM (n = 30, 43.6 +/- 14.2
years) and athlete (n = 60, 43.8 +/- 14.9 years) groups had similar,
supranormal pVO2 (39.5 +/- 9.1 vs. 41.1 +/- 9.1 mL/kg/min, 125 +/- 26 vs.
124 +/- 25% predicted). Recovery kinetics were also similar. However, HCM
participants had worse ventilatory efficiency, including higher early
VE/VCO2 slope (25.4 +/- 4.7 vs. 23.4 +/- 3.1, P = 0.02), higher VE/VCO2
nadir (27.3 +/- 4.0 vs. 25.2 +/- 2.6, P = 0.004) and lower end-tidal CO2
at the ventilatory threshold (42.9 +/- 6.4 vs. 45.7 +/- 4.8 mmHg, P =
0.02). HCM participants were more likely to have abnormally high VE/VCO2
nadir (>30) than athletes (20 vs. 3%, P = 0.02).

CONCLUSION: Even in the setting of similar and supranormal pVO2,
ventilatory efficiency is worse in HCM participants vs. healthy athletes.
Our results demonstrate the utility of CPET beyond pVO2 assessment in
‘grey zone’ athlete cases in which the diagnosis of HCM is being debated.
Copyright © The Author(s) 2025. Published by Oxford University Press
on behalf of the European Society of Cardiology. All rights reserved. For
commercial re-use, please contact reprints@oup.com for reprints and
translation rights for reprints. All other permissions can be obtained
through our RightsLink service via the Permissions link on the article
page on our site-for further information please contact
journals.permissions@oup.com.
Other Abstract
plain-language-summary
We sought to examine exercise test findings in healthy athletes and
equally fit individuals with a form of heart enlargement that commonly
gets confused with ‘athlete’s heart’ called hypertrophic cardiomyopathy
(HCM) to see if elements of the exercise test could distinguish between
these two groups. This is relevant as fit individuals often present for
exercise testing as part of the work up to see if they have HCM or not,
and getting the answer right is important because HCM is amongst the most
common causes of sudden cardiac death in athletes.By design, individuals
with HCM in this study were equally fit as the athletes, with both groups
having fitness levels (‘VO2 max’ levels) around 25% higher than expected
for individuals of similar age and sex.Despite this similar and
supranormal fitness, individuals with HCM had worse ventilatory efficiency
than athletes. This is a metric that reflects how well the heart and lungs
work together to get rid of the waste gas carbon dioxide during exercise.
This finding should focus more attention on this parameter when exercise
tests are being performed to evaluate for HCM in clinical practice.

The usefulness of the modified steep ramp test as a practical exercise test for preoperative risk assessment in patients scheduled for pancreatic surgery.

Driessens H; University of Groningen, Groningen, the Netherlands.
Hoeijmakers LSM; Zwerver ODJ; Wijma AG; Hildebrand ND;
Queisen RRYC; Kuikhoven M; den Dulk M; Olde Damink SWM; Klaase JM; Bongers BC

BACKGROUND: The widespread implementation of a preoperative assessment of
aerobic capacity requires a practical field test. This study investigated
the validity of the modified steep ramp test (SRT) for evaluating
preoperative aerobic capacity and to evaluate its usefulness for
preoperative risk assessment in patients planned for pancreatic surgery.

METHODS: Patients scheduled for pancreatic surgery who preoperatively
performed cardiopulmonary exercise testing (CPET) and the modified SRT
within 14 days were included. To assess its criterion validity, the
correlation between the achieved work rate at peak exercise (WRpeak) at
the modified SRT and oxygen uptake (VO2) at peak exercise (VO2peak) during
CPET was determined. To evaluate the ability of the modified SRT to
correctly classify patients as fit or unfit, receiver operating
characteristic (ROC) analyses were performed based on the CPET VO2peak
cutoff 18.0 ml.kg-1.min-1 and VO2 at the ventilatory anaerobic threshold
(VAT) cutoff 11.0 ml.kg-1.min-1.

RESULTS: Forty-eight patients (21 females) aged 68.7 +/- 7.6 years were
included. Modified SRT WRpeak (W/kg) demonstrated a very strong
correlation with CPET VO2peak (rho = 0.865, r = 0.926). The modified SRT
WRpeak cutoff to most accurately classify patients as fit or unfit was
2.095 W/kg for the CPET VO2peak cutoff (area under the curve (AUC) of
0.948) and the CPET VO2 at the VAT cutoff (AUC of 0.814).

CONCLUSIONS: The modified SRT is a valid short-term practical exercise
test to preoperatively assess aerobic capacity in patients undergoing
pancreatic surgery. A modified SRT performance below 2.1 W/kg seems
clinically most suitable to select candidates for further preoperative
CPET evaluation and/or prehabilitation, given its positive and negative
predictive value.

Utility of Cardiopulmonary Exercise Testing in Assessing Beta-Blocker Efficacy in LQTS: Moving Away From One-Size-Fits-All.

El Assaad I; Division of Cardiology & Cardiovascular Medicine, Cleveland, Ohio, USA.
Heilbronner AK; Zahka K; Hammond B; Patel A; Aziz PF

Journal of Cardiovascular Electrophysiology. 36(9):2287-2295, 2025 Sep. VI 1

OBJECTIVE: To describe our institutional experience with utilizing
cardiopulmonary exercise testing (CPET) to assess for chronotropic
suppression and to compare frequency of life-threatening events (LTEs) on
intentional “submaximal” treatment to those on maximal treatment.

METHODS: We queried our Inherited Arrhythmia Registry and identified
patients with LQTS who were on “submaximal” beta blocker doses (nadolol <
0.75-mg/kg/day & propranolol < 2 mg/kg/day) with at least 6 months follow
up. Adequate beta blockade effect was defined as at least 15% decrease
from maximal HR.

RESULTS: The study included 127 LQTS patients: 47% on maximal therapy,
43% on submaximal therapy, and 10% not receiving treatment. Thirty three
percent of patients were on submaximal therapy due to side effects, none
in patients less than 10 years of age. Baseline characteristics were
similar between the groups. There was no significant difference in LTEs
between maximal and submaximal therapy (8% vs. 5.4%, p = 0.72). During
CPET, patients on maximal therapy were more likely to exhibit adequate
chronotropic suppression (60% vs. 40%, p = 0.01). None of the patients on
submaximal therapy with adequate chronotropic effect experienced LTEs
during follow-up.

CONCLUSIONS: Adequate chronotropic suppression was achieved with
“submaximal” beta blocker dose in 40%. Despite similar baseline risk
profiles, LTEs were not significantly different in patients with
submaximal versus maximal therapy. CPET may be a useful modality to devise
an individualized treatment plan, especially in those who cannot tolerate
the recommended guideline directed dose.

Exploring the limits of exercise capacity in adults with type II diabetes.

Michielsen M; Department of Rehabilitation Sciences, KU Leuven, Leuven, Belgium.
Bekhuis Y; Claes J; Decorte E; De Wilde C; Gojevic T;
Costalunga L; Amyay S; Lazarou V; Daraki D; Kounalaki E; Chatzinikolaou P;
Goetschalckx K; Hansen D; Claessen G; De Craemer M; Cornelissen V

PLoS ONE [Electronic Resource]. 20(9):e0331737, 2025. VI 1

OBJECTIVE: This study investigates the mechanisms behind exercise capacity
in adults with type 2 diabetes mellitus (T2DM), focusing on central and
peripheral components, as described by the Fick equation.

METHODS: A cross-sectional study of 141 adults with T2DM was conducted,
using cardiopulmonary exercise testing, near-infrared spectroscopy (NIRS)
and exercise echocardiography. Participants with sufficient-quality NIRS
data were stratified into tertiles based on percentage predicted VO2peak.
Group comparisons and stepwise regression were used to examine the
contributions of central and peripheral components to VO2peak.

RESULTS: Sixty-seven participants had insufficient quality NIRS data.
Those with lower-quality data were more likely to be female (p < 0.001)
and had a lower exercise capacity (p < 0.001). Among participants with
good-quality NIRS data, those in the lowest fitness tertile were older (p
< 0.01), had a longer diabetes duration (p = 0.04), lower eGFR (p < 0.001)
and more frequent use of beta-blockers (p = 0.02) and diuretics (p =
0.04). Significant differences were observed in peak cardiac output (p <
0.001) and NIRS-derived parameters across fitness groups. Multivariate
regression identified cardiac output as the strongest predictor of
VO2peak, while peripheral oxygen extraction did not improve model
performance.

CONCLUSION: Cardiac output is the primary determinant of exercise
capacity in adults with T2DM. This suggests that muscle perfusion may be
the main limiting factor in relatively fit individuals with T2DM. However,
cardiac output and local muscle perfusion are not directly equivalent, as
mechanical factors, such as intramuscular pressure during high-intensity
exercise, may prevent maximal perfusion.

Blood pressure levels are higher in individuals with type 1 diabetes mellitus compared to healthy subjects during exercise stress test.

Mikeš O; Third Department of Internal Medicine,  Charles University, Prague, Czech Republic.
Prázný M; Šoupal J; Marek J; Matoulek M; Tuka V;

Scientific reports [Sci Rep] 2025 Aug 13; Vol. 15 (1), pp. 29633.
Date of Electronic Publication: 2025 Aug 13.

Type 1 diabetes mellitus (T1DM) is a chronic disease that usually manifests at a younger age and is associated with higher morbidity and mortality compared to the general population. The objective of this study was to assess the blood pressure response to exercise in patients with T1DM with varying durations of diabetes and with respect to the determinants of systolic blood pressure (SBP) and diastolic blood pressure (DBP) during the exercise stress test. This cross-sectional exploratory study included 52 patients (35 with T1DM aged &lt; 35 years and 17 aged &gt; 35 years) and 25 control subjects. All participants were untrained and underwent a cardiopulmonary exercise stress test using a cycle ergometer and their BP was measured manually. Compared to control subjects, both younger and older patients with T1DM had higher SBP and DBP at submaximal exercise load 0,5 W/kg (SBP 124 ± 18; 142 ± 17; 146 ± 19 mmHg, p = 0.0004, respectively, and DBP 75 ± 10; 84 ± 7; 82 ± 7 mmHg, p = 0.0015, respectively), and at peak exercise (SBP 170 ± 24; 188 ± 26; 192 ± 23 mmHg, p = 0.0006, respectively. BP during exercise in T1DM patients in multivariate model was influenced by resting SBP, and diabetes duration. Patients with T1DM exhibited impaired BP control during exercise, which may serve as an early marker of heightened cardiovascular risk.

Comparison of exercise training modalities and change in peak oxygen consumption in heart failure with preserved ejection fraction: a secondary analysis of the OptimEx-Clin trial.

Mueller S; TUM University Hospital, Georg-Brauchle-Ring 56, 80992 Munich, Germany.
Kabelac M; Fegers-Wustrow I; Winzer EB; Gevaert AB; Beckers P;
Haller B; Edelmann F; Christle JW; Haykowsky MJ; Sachdev V; Kitzman DW;
Linke A; Adams V; Wisloff U; Pieske B; van Craenenbroeck E; Halle M

European Journal of Preventive Cardiology. 32(11):926-936, 2025 Aug 25.

AIMS: Exercise training (ET) is an effective therapy in heart failure with
preserved ejection fraction (HFpEF), but the influence of different ET
characteristics is unclear. We aimed to evaluate the associations between
ET frequency, duration, intensity [% heart rate reserve (%HRR)] and
estimated energy expenditure (EEE) with the change in peak oxygen
consumption (VO2) over 3 months of moderate continuous training (MCT,
5x/week) or high-intensity interval training (HIIT, 3x/week) in HFpEF.

METHODS AND RESULTS: ET duration and heart rate (HR) were recorded with a
smartphone application. EEE was calculated using the HR data during ET and
the individual HR-VO2 relationships during cardiopulmonary exercise
testing. Differences between groups and associations between ET
characteristics and peak VO2 change were assessed with linear regression
analyses. Peak VO2 improved by 9.2 +/- 13.2% after MCT and 8.7 +/- 15.9%
after HIIT (P = 0.67). The average EEE of 1 HIIT session was equivalent to
~1.42 MCT sessions and when adjusted for EEE, the mean difference between
MCT and HIIT was -0.1% (P = 0.98). For both MCT and HIIT, peak VO2 change
was positively associated with ET frequency (MCT: R2 = 0.103; HIIT: R2 =
0.149) and duration/week (MCT: R2 = 0.120; HIIT: R2 = 0.125; all P <
0.05). Average %HRR was negatively associated with peak VO2 change in MCT
(R2 = 0.101; P = 0.034), whereas no significant association was found in
HIIT (P = 0.234). Multiple regression analyses explained ~1/3 of the
variance in peak VO2 change.

CONCLUSION: In HFpEF, isocaloric HIIT and MCT seem to be equally
effective over 3 months. Within each mode, increasing ET frequency or
duration/week may be more effective to improve peak VO2 than increasing ET
intensity. Copyright &#xa9; The Author(s) 2024. Published by Oxford
University Press on behalf of the European Society of Cardiology.

Exploring the association between socioeconomic status and cardiopulmonary exercise testing measures: A cohort study based on routinely collected data.

Shrestha, D; Lancaster Medical School, Lancaster University, Lancaster, United Kingdom.;
Wisely, N; Bampouras, T; Subar, D et al

PloS one,2025 Aug 12

  • Background: Cardiopulmonary exercise testing (CPET) provides objective measures of cardiorespiratory fitness and can support surgical risk stratification. As socioeconomic status is a factor known to influence patient health and outcomes, we analysed how CPET-derived measures vary across levels of socioeconomic status in patients being considered for elective surgery.
  • Methods: A database of patients who underwent CPET between 2011 and 2024 was analysed. Measures including oxygen consumption (V̇O₂) at gas exchange threshold (GET), peak V̇O₂, and ventilatory equivalent for carbon dioxide (VE/V̇CO₂) were compared across socioeconomic deprivation quintiles. Multivariable linear and logistic regression models assessed the effects of age, sex, body mass index (BMI), Revised Cardiac Risk Index (RCRI), and deprivation quintiles on CPET measures. Hierarchical regression models incorporating the Indices of Deprivation (IoD) domains and Access to Healthy Assets and Hazards (AHAH) scores determined whether wider social determinants of health explained the variance in CPET measures.
  • Results: A total of 3344 patients (2476 male) were included, referred prior to procedures in vascular (2006), colorectal (650), upper GI (267), urology (205), and other (216) surgical specialties. Lower socioeconomic status was associated with younger age (p < 0.001), higher BMI (p = 0.022), higher smoking prevalence (p < 0.001), and RCRI ≥3 (p = 0.013). CPET measures were lower in the most deprived quintile (Q1) compared to the least (Q5): mean GET was 11.0 vs. 11.5 ml·kg-1·min-1 and peak V̇O2 was 14.8 vs. 16.3 ml·kg-1·min-1 (p < 0.05). Deprivation remained an independent predictor of lower GET and peak V̇O2, even after adjustment. Several IoD and AHAH domains explained small but significant variance in CPET measures.
  • Conclusion: Patients from more deprived areas exhibit risk factors for poor health and lower cardiorespiratory fitness as measured by CPET. These findings add to our understanding of socioeconomic disparities in physiological reserve among surgical patients and may support the need for more holistic approaches to peri-operative care.

Cardiopulmonary exercise testing in hypertrophic cardiomyopathy: the role of reduced O2 pulse and chronotropic incompetence in myocardial adaptation.

Willixhofer, R; Centro Cardiologico Monzino, IRCCS, Via Parea 4, Milan 20138, Italy.;
Mapelli, M; Baracchini, N; Campana, N; et al

European journal of preventive cardiology,2025 Aug 07

  • Aims: Hypertrophic cardiomyopathy (HCM) is associated with functional limitations during exercise. We aimed to evaluate oxygen pulse (O2p) as a stroke volume (SV) surrogate and to propose a new HCM classification (RoMa) based on haemodynamic profiles during exercise: predicted peak O2p (O2pp) and peak heart rate (HRpp).
  • Methods and Results: This multicentre, prospective study included 90 clinically stable HCM patients who underwent cardiopulmonary exercise testing with simultaneous impedance cardiography (PhysioFlow®). We assessed the relationship between SV and O2p. Patients were stratified into four groups based on HRpp (≥80% predicted) and O2pp (≥100% predicted): RoMa I (high HRpp-high O2pp), RoMa II (high HRpp-low O2pp), RoMa III (low HRpp-high O2pp), and RoMa IV (low HRpp-low O2pp). Oxygen uptake (VO2), minute ventilation-to-carbon dioxide production (VE/VCO2) slope, SV, and mitral regurgitation (MR) were analysed. Patients (80% male, 53 [42-64] years) had preserved left ventricular ejection fraction (62 [58-68]%) and peakVO2 (23.1 ± 7.8 mL/min/kg = 81 ± 21% predicted). SV correlated with O2p (r = 0.48, P < 0.001; β = 3.59, P < 0.001). Resting moderate to severe MR was more prevalent in RoMa class IV (41%) vs. RoMa I (18%, P = 0.038). PeakVO2 declined across groups, from 29.7 ± 8.3 (RoMa I) to 16.2 ± 5.1 mL/min/kg (RoMa IV, P < 0.001). VE/VCO2 slope increased from 26.4 ± 4.5 (RoMa I) to 38.6 ± 6.0 (RoMa IV, P = 0.002). Peak SV decreased from 128.7 ± 24.8 (RoMa I) to 104.7 ± 28.0 mL (RoMa IV, P = 0.019), while rest to peak SV difference dropped from 38.6 (30.4-52.8) to 15.8 (8.2-27.9) mL (P = 0.002).
  • Conclusion: SV and O2p are significantly related, and the RoMa classification effectively distinguished HCM patients.
  • Key Findings: O2p is a reliable indicator of SV, helping to better understand exercise limitations in HCM patients.The newly introduced RoMa classification effectively distinguishes different levels of exercise impairment in HCM, linking poorer heart function to lower oxygen uptake and higher breathing inefficiency.